We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings

By MedImaging International staff writers
Posted on 12 Mar 2025
Print article
Image: The INSIGHT MMG AI-powered mammography analysis solution (Photo courtesy of Lunit)
Image: The INSIGHT MMG AI-powered mammography analysis solution (Photo courtesy of Lunit)

A new study has revealed that an artificial intelligence (AI)-powered solution significantly improves cancer detection in single-reader mammography settings without increasing recall rates, offering a transformative tool for countries that rely on single-reader mammography screenings.

This pioneering prospective study validated the real-world effectiveness of AI-driven mammography screening within South Korea's national breast cancer screening program. Conducted as the first large-scale, multicenter prospective study in a single-reading setting globally, the research highlights the significant improvements AI-assisted mammography interpretation brings to breast cancer detection, all while maintaining steady recall rates. Led by Soonchunhyang University Seoul Hospital (Seoul, South Korea), in collaboration with breast and general radiologists from six top academic hospitals in South Korea, the study analyzed 24,543 women aged 40 and older who underwent routine biennial mammography (2D full-field digital mammogram) between February 2021 and December 2022 as part of Korea's national screening initiative.

The study compared the performance of breast radiologists interpreting screening mammograms with and without Lunit’s (Seoul, South Korea) AI-based computer-aided detection, Lunit INSIGHT MMG. Results indicated that AI-assisted radiologists detected 13.8% more screen-detected breast cancers compared to those using traditional methods alone. The cancer detection rate (CDR) increased from 5.01 (per 1,000) to 5.70 with AI assistance, while recall rates (RRs) remained statistically unchanged, ensuring enhanced clinical effectiveness while avoiding unnecessary additional recalls. Additionally, AI assistance significantly improved the detection of smaller tumors and node-negative cancers, crucial indicators of early-stage detection. The study also assessed the impact of Lunit INSIGHT MMG on general radiologists without breast imaging expertise through a simulated retrospective study. The findings, published in Nature Communications, showed a 26.4% increase in CDRs for general radiologists, improving from 3.87 to 4.89 per 1,000, highlighting AI’s potential to assist radiologists with varying expertise.

This study builds upon Lunit INSIGHT MMG's established ability to enhance breast cancer detection. The findings are poised to influence breast cancer screening practices globally, especially in countries where single-reading mammography is standard. By demonstrating AI’s ability to improve radiologist accuracy without raising recall rates, the study provides essential data supporting AI’s role in optimizing cancer detection while alleviating radiologists’ workload. This is particularly pertinent as many countries face a shortage of specialized breast imaging professionals, making AI a crucial tool for improving efficiency and maintaining high diagnostic standards. With growing evidence supporting AI's effectiveness in breast cancer screening, Lunit is advancing its global adoption. Lunit INSIGHT MMG has already been implemented in national screening programs in Australia, Sweden, Iceland, Singapore, Saudi Arabia, and Qatar, helping healthcare systems increase efficiency and improve diagnostic accuracy.

"This latest prospective study in South Korea further solidifies Lunit INSIGHT MMG's potential as an indispensable tool in breast cancer screening. Whether in a single-reader or double-reader setting, AI can serve as a powerful force multiplier, assisting radiologists in detecting cancer earlier and more accurately," said Brandon Suh, CEO of Lunit. "As AI adoption accelerates, we remain committed to driving innovation and making AI-powered cancer screening the new standard of care. By working closely with healthcare providers worldwide, we aim to ensure that AI benefits as many patients as possible."

Related Links:
Lunit
Soonchunhyang University Seoul Hospital

Digital X-Ray Detector Panel
Acuity G4
New
HF Stationary X-Ray Machine
TR20G
Mini C-arm Imaging System
Fluoroscan InSight FD
New
X-Ray Illuminator
X-Ray Viewbox Illuminators

Print article

Channels

MRI

view channel
Image

Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer

Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read more

Ultrasound

view channel
Image: The model trained on echocardiography, can identify liver disease in people without symptoms (Photo courtesy of 123RF)

Artificial Intelligence Detects Undiagnosed Liver Disease from Echocardiograms

Echocardiography is a diagnostic procedure that uses ultrasound to visualize the heart and its associated structures. This imaging test is commonly used as an early screening method when doctors suspect... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.